NASDAQ:ALKS
Alkermes plc Stock News
$27.07
-0.180 (-0.661%)
At Close: Mar 28, 2024
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 20'th Mar 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
3 Reasons Why Alkermes (ALKS) Is a Great Growth Stock
01:46pm, Wednesday, 13'th Mar 2024
Alkermes (ALKS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Alkermes (ALKS) is a Strong Momentum Stock
10:50am, Tuesday, 12'th Mar 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Alkermes (ALKS) is a Strong Growth Stock
10:51am, Friday, 08'th Mar 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Alkermes (ALKS) Outpaced the Stock Market Today
07:16pm, Thursday, 07'th Mar 2024
Alkermes (ALKS) concluded the recent trading session at $29.45, signifying a +1.76% move from its prior day's close.
Alkermes (ALKS) Stock Declines While Market Improves: Some Information for Investors
07:16pm, Thursday, 29'th Feb 2024
In the closing of the recent trading day, Alkermes (ALKS) stood at $29.69, denoting a -0.37% change from the preceding trading day.
Why Alkermes (ALKS) is a Top Momentum Stock for the Long-Term
10:56am, Friday, 23'rd Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024
01:04pm, Wednesday, 21'st Feb 2024
Biotech stocks are often at the forefront of innovation. These are the companies we hear about that are driving breakthroughs in healthcare.
Why Alkermes (ALKS) is a Top Growth Stock for the Long-Term
10:51am, Wednesday, 21'st Feb 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript
03:08pm, Thursday, 15'th Feb 2024
Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript
Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates
02:35pm, Thursday, 15'th Feb 2024
Alkermes' (ALKS) earnings and revenues outpace estimates in the fourth quarter of 2023. Strong growth in proprietary products drives year-over-year revenues.
Compared to Estimates, Alkermes (ALKS) Q4 Earnings: A Look at Key Metrics
10:31am, Thursday, 15'th Feb 2024
Although the revenue and EPS for Alkermes (ALKS) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Str
7 Biotech Stocks Fighting America's Deadliest Diseases
04:10pm, Thursday, 08'th Feb 2024
Unlike many other market segments, biotech stocks stand out for their direct relevance. For example, investors who typically wager on aerospace and defense plays usually aren't fighter pilots.
Alkermes (ALKS) to Report Q4 Results: Wall Street Expects Earnings Growth
11:06am, Thursday, 08'th Feb 2024
Alkermes (ALKS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alkermes (ALKS) Stock Falls Amid Market Uptick: What Investors Need to Know
07:16pm, Wednesday, 07'th Feb 2024
The latest trading day saw Alkermes (ALKS) settling at $26.70, representing a -1.26% change from its previous close.